Profile
Home  /   Staff  /   Researcher Profiles  /  Prof. Xu Zhang  /  Research Funding

Prof. Xu Zhang

Work Phone (02) 4921 8906
Fax (02) 4921 7311
Email
Office LS3-49, Life Sciences Building

Funding

Summary

Number of grants 34
Total funding $5,137,426

For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.

Seeking students for this project. - Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2013 (4 grants)

Functional consequences of epigenetic repression of PIB5PA in melanoma$359,250
Funding Body: Cancer Council NSW

Targeting PP2A to improve the therapeutic efficacy of mutant BRAF inhibitors in melanoma$359,250
Funding Body: Cancer Council NSW

Leica TP 1020 Automatic Tissue Processor for histology applications$35,000
Funding Body: NHMRC (National Health & Medical Research Council)

Ultra-Low Temperature Cryogenic Freezer$24,596
Funding Body: NHMRC (National Health & Medical Research Council)

2012 (5 grants)

Targeting Histone Deacetylases to Overcome Resistance of BRAFV600E Melanoma Cells to Apoptosis$346,974
Funding Body: NHMRC (National Health & Medical Research Council)

The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$294,301
Funding Body: Cancer Institute NSW

High-Resolution Isoelectric Phosphoprotein Signalling System for Signalling Research, Biomarker Validation and Drug Development – Equipment Grant$143,394
Funding Body: Hunter Medical Research Institute

Microscopic illumination system for advanced fluorescent protein technology$34,000
Funding Body: NHMRC (National Health & Medical Research Council)

A p53-Mediated Pro-Survival Signaling Pathway in Human Melanoma Progression and Resistance to Treatment$20,000
Funding Body: University of Newcastle

2011 (6 grants)

Overcoming resistance of human metastatic melanoma to treatment$570,640
Funding Body: NHMRC (National Health & Medical Research Council)

Targeting pro-survival mechanisms to sensitize human melanoma to immunotherapy$359,250
Funding Body: Cancer Council NSW

Overcoming Resistance of Metastatic Melanoma to Treatment: 53 regulation of Mcl-1 via a microRNA-Mediated Pathway in Melanoma progression and Resistance to Chemotherapy$123,498
Funding Body: Cancer Institute NSW

Regulation of BimS splicing in response of human melanoma cells to inhibition of BRAFVV600E$25,000
Funding Body: Hunter Medical Research Institute

Targeting Pro-Survival Mechanisms to Sensitize Human Melanoma to Immunotherapy$25,000
Funding Body: University of Newcastle

The Role of Phosphatidylinositol 4, 5-Bisphosphate 5-Phosphatase A (PIB5PA) in Regulation of PI3K/Akt Signalling in Melanoma$24,000
Funding Body: Hunter Medical Research Institute

2010 (4 grants)

Transcriptional regulation of the expression of Mcl-1 in melanoma cell under ER stress$144,300
Funding Body: NHMRC (National Health & Medical Research Council)

Melanoma Institute Australia Translational Research Program$58,405
Funding Body: Cancer Institute NSW

Targeting Pro-Survival Mechanisms to Sensitize Human Melanoma to Immunotherapy$48,200
Funding Body: Cancer Institute NSW

The role of micro-RNA-149 in Regulation of Mcl-1 in Human Melanoma under stress$20,000
Funding Body: Hunter Children`s Research Foundation

2009 (4 grants)

Targeting adaptive mechanisms to endoplasmic reticulum stress in melanoma$491,250
Funding Body: NHMRC (National Health & Medical Research Council)

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$272,000
Funding Body: Cancer Council NSW

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$75,000
Funding Body: Cancer Australia

FACSAria$30,000
Funding Body: NHMRC (National Health & Medical Research Council)

2008 (1 grants)

Colibri high-performance LED illumination system for fluorescence live cell microscopy$23,225
Funding Body: NHMRC (National Health & Medical Research Council)

2007 (4 grants)

Characterization of p53 isoforms in human melanoma: do they play a role in chemoresistance?$75,000
Funding Body: Cure Cancer Australia Foundation

The role of p53 Isoforms in chemoresistances of human melanoma$20,000
Funding Body: Hunter Medical Research Institute

The role of p53 isoforms in chemoresistance of human melanoma. $0
Funding Body: Newcastle Mater Misericordiae Hospital

molecular predictors of risk, progression and treatment response in melanoma$0
Funding Body: National Health & Medical Research Council

2006 (1 grants)

PRC - Priority Research Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine (CIBM)$621,143
Funding Body: University of Newcastle

2005 (4 grants)

Overcoming resistance of human melanoma to chemotherapy$492,750
Funding Body: NHMRC (National Health & Medical Research Council)

PULSE Young Medical Researcher of the Year Award$5,000
Funding Body: Hunter Medical Research Institute

Overcoming Resistance of Melanoma to Chemotherapy$0
Funding Body: National Health & Medical Research Council

Overcoming Resistance of Melanoma to Chemotherapy: Are Melanoma Stem Cells Key Targets? $0
Funding Body: Cancer Institute NSW

2003 (1 grants)

Regulation of TNF Apoptosis Inducing Ligand (TRAIL) Receptor Expression in Human Melanoma Cells.$17,000
Funding Body: Hunter Medical Research Institute